Advanced Hadamard-encoded editing of seven low-concentration brain metabolites: Principles of HERCULES

Purpose: To demonstrate the framework of a novel Hadamard‐encoded spectral editing approach for simultaneously detecting multiple low‐concentration brain metabolites in vivo at 3T. Methods: HERCULES (Hadamard Editing Resolves Chemicals Using Linear‐combination Estimation of Spectra) is a four‐step Hadamard‐encoded editing scheme. 20‐ms editing pulses are applied at: (A) 4.58 and 1.9 ppm; (B) 4.18 and 1.9 ppm; (C) 4.58 ppm; and (D) 4.18 ppm. Edited signals from &ggr;‐aminobutyric acid (GABA), glutathione (GSH), ascorbate (Asc), N‐acetylaspartate (NAA), N‐acetylaspartylglutamate (NAAG), aspartate (Asp), lactate (Lac), and likely 2‐hydroxyglutarate (2‐HG) are separated with reduced signal overlap into distinct Hadamard combinations: (A+B+C+D); (A+B–C–D); and (A–B+C–D). HERCULES uses a novel multiplexed linear‐combination modeling approach, fitting all three Hadamard combinations at the same time, maximizing the amount of information used for model parameter estimation, in order to quantify the levels of these compounds. Fitting also allows estimation of the levels of total choline (tCho), myo‐inositol (Ins), glutamate (Glu), and glutamine (Gln). Quantitative HERCULES results were compared between two grey‐ and white‐matter‐rich brain regions (11 min acquisition time each) in 10 healthy volunteers. Coefficients of variation (CV) of quantified measurements from the HERCULES fitting approach were compared against those from a single‐spectrum fitting approach, and against estimates from short‐TE PRESS data. Results: HERCULES successfully segregates overlapping resonances into separate Hadamard combinations, allowing for the estimation of levels of seven coupled metabolites that would usually require a single 11‐min editing experiment each. Metabolite levels and CVs agree well with published values. CVs of quantified measurements from the multiplexed HERCULES fitting approach outperform single‐spectrum fitting and short‐TE PRESS for most of the edited metabolites, performing only slightly to moderately worse than the fitting method that gives the lowest CVs for tCho, NAA, NAAG, and Asp. Conclusion: HERCULES is a new experimental approach with the potential for simultaneous editing and multiplexed fitting of up to seven coupled low‐concentration and six high‐concentration metabolites within a single 11‐min acquisition at 3T. HighlightsHERCULES can simultaneously edit up to seven low‐concentration metabolites within a single experiment at 3T.HERCULES is based on a novel Hadamard‐encoded spectral editing scheme.Novel multiplexed fitting approach exploits all available spectral information.

[1]  R. Gruetter,et al.  1H NMR detection of vitamin C in human brain in vivo , 2004, Magnetic resonance in medicine.

[2]  Melissa Terpstra,et al.  Noninvasive quantification of T2 and concentrations of ascorbate and glutathione in the human brain from the same double‐edited spectra , 2011, NMR in biomedicine.

[3]  A. J. Kresge,et al.  Proton NMR Chemical Shifts of Hydronium and Hydroxyl Ions , 1963 .

[4]  Kamil Ugurbil,et al.  Noninvasive quantification of human brain ascorbate concentration using 1H NMR spectroscopy at 7 T , 2010, NMR in biomedicine.

[5]  J Star-Lack,et al.  In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. , 1998, Journal of magnetic resonance.

[6]  G. Bloch,et al.  Brain GABA editing without macromolecule contamination , 2001, Magnetic resonance in medicine.

[7]  Melissa Terpstra,et al.  Noninvasive quantification of ascorbate and glutathione concentration in the elderly human brain , 2011, NMR in biomedicine.

[8]  J. Frahm,et al.  Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS , 1997, NMR in biomedicine.

[9]  Kimberly L Chan,et al.  Simultaneous measurement of Aspartate, NAA, and NAAG using HERMES spectral editing at 3 Tesla , 2017, NeuroImage.

[10]  Peter B Barker,et al.  In vivo quantitative proton MRSI study of brain development from childhood to adolescence , 2002, Journal of magnetic resonance imaging : JMRI.

[11]  Jun Shen,et al.  In vivo detection of gray and white matter differences in GABA concentration in the human brain , 2006, NeuroImage.

[12]  A. Henning,et al.  In vivo estimation of transverse relaxation time constant (T2) of 17 human brain metabolites at 3T , 2018, Magnetic resonance in medicine.

[13]  Kimberly L Chan,et al.  Frequency and phase correction for multiplexed edited MRS of GABA and glutathione , 2018, Magnetic resonance in medicine.

[14]  Peter B Barker,et al.  J‐difference editing of gamma‐aminobutyric acid (GABA): Simulated and experimental multiplet patterns , 2013, Magnetic resonance in medicine.

[15]  Josh Star-Lack,et al.  In VivoLactate Editing with Simultaneous Detection of Choline, Creatine, NAA, and Lipid Singlets at 1.5 T Using PRESS Excitation with Applications to the Study of Brain and Head and Neck Tumors☆ , 1998 .

[16]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[17]  Andrew A Maudsley,et al.  Regional distributions of brain glutamate and glutamine in normal subjects , 2016, NMR in biomedicine.

[18]  G B Matson,et al.  A detailed analysis of localized J‐difference GABA editing: theoretical and experimental study at 4 T , 2008, NMR in biomedicine.

[19]  A. Doerfler,et al.  In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? , 2010, European journal of radiology.

[20]  R. Edden,et al.  Effects of eddy currents on selective spectral editing experiments at 3T , 2018, Journal of magnetic resonance imaging : JMRI.

[21]  Kimberly L. Chan,et al.  Simultaneous detection of glutathione and lactate using spectral editing at 3 T , 2017, NMR in biomedicine.

[22]  Jun Shen,et al.  Retrospective correction of frequency drift in spectral editing: The GABA editing example , 2017, NMR in biomedicine.

[23]  Jullie W Pan,et al.  Quantitative spectroscopic imaging of the human brain , 1998, Magnetic resonance in medicine.

[24]  D. Weinberger,et al.  Reproducibility of prefrontal γ‐aminobutyric acid measurements with J‐edited spectroscopy , 2011, NMR in biomedicine.

[25]  M. Garwood,et al.  Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.

[26]  R. Mattson,et al.  Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Michael Schär,et al.  Prospective frequency correction for macromolecule‐suppressed GABA editing at 3T , 2016, Journal of magnetic resonance imaging : JMRI.

[28]  Peter Jezzard,et al.  Advanced processing and simulation of MRS data using the FID appliance (FID‐A)—An open source, MATLAB‐based toolkit , 2017, Magnetic resonance in medicine.

[29]  Kimberly L Chan,et al.  Hadamard editing of glutathione and macromolecule‐suppressed GABA , 2018, NMR in biomedicine.

[30]  Kimberly L. Chan,et al.  Simultaneous editing of GABA and glutathione at 7T using semi‐LASER localization , 2018, Magnetic resonance in medicine.

[31]  Martin Tegenthoff,et al.  Impact of frequency drift on gamma‐aminobutyric acid‐edited MR spectroscopy , 2014, Magnetic resonance in medicine.

[32]  Helene Ratiney,et al.  MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. , 2010, Magnetic resonance imaging.

[33]  D. van Ormondt,et al.  Improved algorithm for noniterative time-domain model fitting to exponentially damped magnetic resonance signals , 1987 .

[34]  Ovidiu C. Andronesi,et al.  Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy , 2012, Science Translational Medicine.

[35]  Rolf Gruetter,et al.  Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference‐edited spectra , 2003, Magnetic resonance in medicine.

[36]  Dost Öngür,et al.  Quantification of J‐resolved proton spectra in two‐dimensions with LCModel using GAMMA‐simulated basis sets at 4 Tesla , 2009, NMR in biomedicine.

[37]  Wolfgang Bogner,et al.  Spatial variability and reproducibility of GABA‐edited MEGA‐LASER 3D‐MRSI in the brain at 3 T , 2016, NMR in biomedicine.

[38]  Blaise deB. Frederick,et al.  Grey and white matter GABA level differences in the human brain using two‐dimensional, J‐resolved spectroscopic imaging , 2005, NMR in biomedicine.

[39]  M. Terpstra,et al.  Noninvasive quantification of human brain antioxidant concentrations after an intravenous bolus of vitamin C , 2011, NMR in biomedicine.

[40]  Kimberly L Chan,et al.  Echo time optimization for J‐difference editing of glutathione at 3T , 2017, Magnetic resonance in medicine.

[41]  Peter Jezzard,et al.  Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain , 2015, Magnetic resonance in medicine.

[42]  Michael Schär,et al.  HERMES: Hadamard encoding and reconstruction of MEGA‐edited spectroscopy , 2016, Magnetic resonance in medicine.

[43]  T. Cloughesy,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[44]  Dinesh Rakheja,et al.  2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients , 2011, Nature Medicine.

[45]  Hong Wu,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[46]  Karl Young,et al.  Corrigendum: Proton NMR chemical shifts and coupling constants for brain metabolites. Govindaraju V, Young K, Maudsley AA, NMR Biomed. 2000; 13: 129–153 , 2015, NMR in biomedicine.

[47]  Mark J Lowe,et al.  In vivo magnetic resonance spectroscopy measurement of gray-matter and white-matter gamma-aminobutyric acid concentration in sensorimotor cortex using a motion-controlled MEGA point-resolved spectroscopy sequence. , 2011, Magnetic resonance imaging.

[48]  Martin G Pomper,et al.  In vivo differentiation of N‐acetyl aspartyl glutamate from N‐acetyl aspartate at 3 Tesla , 2007, Magnetic resonance in medicine.

[49]  Michael-Paul Schallmo,et al.  Big GABA: Edited MR spectroscopy at 24 research sites , 2017, NeuroImage.

[50]  G J Barker,et al.  Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.

[51]  Jun Shen,et al.  Fast computation of full density matrix of multispin systems for spatially localized in vivo magnetic resonance spectroscopy , 2017, Medical physics.

[52]  Peter B Barker,et al.  Spatial effects in the detection of γ‐aminobutyric acid: Improved sensitivity at high fields using inner volume saturation , 2007, Magnetic resonance in medicine.

[53]  R. Edden,et al.  Macromolecule‐suppressed GABA‐edited magnetic resonance spectroscopy at 3T , 2012, Magnetic resonance in medicine.

[54]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[55]  A. Maudsley,et al.  Comparison of spectral fitting methods for overlapping J‐coupled metabolite resonances , 2010, Magnetic resonance in medicine.

[56]  Darren Price,et al.  Methodology for improved detection of low concentration metabolites in MRS: Optimised combination of signals from multi-element coil arrays , 2014, NeuroImage.

[57]  Rolf Gruetter,et al.  Detection of an antioxidant profile in the human brain in vivo via double editing with MEGA‐PRESS , 2006, Magnetic resonance in medicine.

[58]  Richard A. E. Edden,et al.  Simultaneous edited MRS of GABA and glutathione , 2016, NeuroImage.